NEW YORK (GenomeWeb News) ¯ Oxford Gene Technology yesterday said it has granted Phalanx Biotech Group a license to its Southern array patents.
The deal enables Taiwan-based Phalanx to sell arrays, including its whole-genome OneArray platform, for gene expression-profile studies in the US.
The license is valid for the patents’ lifetime.
Financial details were not disclosed.